Preparation and physicochemical and preclinical evaluations of recrystallized celecoxib.

PDA J Pharm Sci Technol

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India.

Published: December 2007

The aim of the present study is to increase the aqueous solubility of celecoxib by recrystallization from distilled water, Tween-80, and polyethylene glycol-400. The prepared crystals were evaluated for various physicochemical evaluations, dissolution rate, and in vivo performance like analgesic activity (by writhing and hot plate method) and pharmacokinetics in mice. The practical yield of the crystals ranged between 83 and 98%, and celecoxib content was more than 99%. Celecoxib showed an almost 5-fold increase in solubility when recrystallized in the presence of Tween-80 (2%). The dissolution rates of celecoxib from the co-crystal forms were considerably higher than that of plain celecoxib. The infrared and differential scanning calorimetry studies indicated the absence of a well-defined interaction between celecoxib and carriers. The differential scanning calorimetry and X-ray diffraction studies indicated the amorphization or partial amorphization of the drug. The scanning electron microscopy showed fluffy, porous, and fine particles in recrystallized celecoxib. The particle size of prepared co-crystals was considerably reduced in comparison with plain celecoxib. The crystals prepared with Tween-80 (2%) showed significantly higher analgesic activity than plain celecoxib. In pharmacokinetic study, the prepared crystals exhibited significantly high and rapid absorption along with improved bioavailability.

Download full-text PDF

Source

Publication Analysis

Top Keywords

plain celecoxib
12
celecoxib
10
recrystallized celecoxib
8
prepared crystals
8
analgesic activity
8
differential scanning
8
scanning calorimetry
8
studies indicated
8
preparation physicochemical
4
physicochemical preclinical
4

Similar Publications

Article Synopsis
  • - Chronic recurrent multifocal osteomyelitis (CRMO) is a nonbacterial bone disease in children that can be mistaken for infections or tumors, making early diagnosis and treatment crucial
  • - A 10-year-old boy experienced pain and swelling in his ankle; initial tests were inconclusive, but four years later, he showed similar symptoms, leading to further imaging and biopsies that confirmed CRMO
  • - The boy was treated with medications like celecoxib and infliximab, resulting in improved symptoms and remission over two years, although he developed a skin condition called palmoplantar pustular psoriasis that is often associated with CRMO
View Article and Find Full Text PDF

Conservative treatments for early osteoarthritis (OA) of the knee included the use of non-steroid anti-inflammatory drugs (NSAIDs) and intra-articular hyaluronic acid (HA) injection. Recently, several animal studies reported that extracorporeal shockwave therapy (ESWT) demonstrated chondroprotective effects on knee OA. The present study compared the efficacy of oral NSAIDs, HA injection, and noninvasive ESWT for early OA of the knee.

View Article and Find Full Text PDF

3D-Printed Mesoporous Carrier System for Delivery of Poorly Soluble Drugs.

Pharmaceutics

July 2021

Division of Nanotechnology and Functional Materials, Department of Materials Science and Engineering, Uppsala University, Box 35, SE-751 03 Uppsala, Sweden.

Fused deposition modelling (FDM) is the most extensively employed 3D-printing technique used in pharmaceutical applications, and offers fast and facile formulation development of personalized dosage forms. In the present study, mesoporous materials were incorporated into a thermoplastic filament produced via hot-melt extrusion and used to produce oral dosage forms via FDM. Mesoporous materials are known to be highly effective for the amorphization and stabilization of poorly soluble drugs, and were therefore studied in order to determine their ability to enhance the drug-release properties in 3D-printed tablets.

View Article and Find Full Text PDF

Background And Hypothesis: Heterotopic ossification (HO) is a recognized sequela after trauma and arthroplasty. The purpose of this study was to evaluate the therapeutic effect of celecoxib on HO. We hypothesized that celecoxib may inhibit the progression of initiated HO.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!